Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

P11717 (MPRI_HUMAN) Homo sapiens (Human)

Cation-independent mannose-6-phosphate receptor UniProtKBInterProSTRINGInteractive Modelling

2491 aa; Sequence (Fasta)

Available Structures

24 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
COMPLEX STRUCTURE OF HUMAN IGF2R DOMAINS 11-13 BOUND TO IGF-II Heteromer
P01344;
1516-1990
NAG;NAG;
Assess
Complex structure of E4 mutant human IGF2R domain 11 bound to IGF-II Heteromer
P01344;
1508-1647
Assess
Architecture of the ESCPE-1 membrane coat Heteromer
Q13596; Q9Y5X3;
2347-2377
Assess
Complex of GGA3-VHS Domain and CI-MPR C-terminal Phosphopeptide Heteromer
Q9NZ52;
2484-2491
Assess
GGA3 VHS domain complexed with C-terminal peptide from cation-independent mannose 6-phosphate recep… Heteromer
Q9NZ52;
2484-2491
Assess
VHS Domain of human GGA1 complexed with cation-independent M6PR C-terminal Peptide Heteromer
Q9UJY5;
2485-2491
IOD;
Assess
N-terminal 5 domains of IGFIIRmonomer43-763
NAG;
Assess
N-terminal 5 domains of CI-MPRmonomer43-762
NAG;
Assess
Human cation-independent mannose 6-phosphate/IGF2 receptor domains 7-11monomer934-1646
NAG;SO4;NAG;
Assess
STRUCTURE OF HUMAN IGF2R DOMAINS 11-14monomer1516-2128
NAG;CL;
Assess
Human cation-independent mannose 6-phosphate/ IGF2 receptor domains 9-10monomer1225-1509
NAG;
Assess
STRUCTURE OF HUMAN IGF2R DOMAINS 11-12monomer1516-1797
NAG;
Assess
NMR solution structure ensemble of 3-4D mutant domain 11 IGF2R in complex with IGF2 (domain 11 stru…monomer1508-1649
Assess
NMR studies on the interaction of Insulin-Growth Factor II (IGF-II) with IGF2R domain 11monomer1510-1651
Assess
NMR solution structure ensemble of 3-4D mutant domain 11 IGF2Rmonomer1508-1649
Assess
Mutated Domain 11 of the Cytoplasmic region of the Cation-independent mannose-6-phosphate receptormonomer1508-1647
Assess
Human cation-independent mannose 6-phosphate/ IGF2 receptor domain 8monomer1082-1220
CL;NA;
Assess
X-ray crystallographic structure of a high affinity IGF2 antagonist (Domain11 AB5 RHH) based on hum…monomer1511-1647
GOL;EDO;SO4;
Assess
HUMAN MIR-RECEPTOR, REPEAT 11monomer1513-1647
BR;
Assess
Human MIR-receptor, repeat 11monomer1514-1647
Assess
Human IGF2R domain 11monomer1515-1647
SO4;
Assess
Human IGF2R domain 11monomer1515-1647
Assess
Crystal structure of the SNX5 PX domain in complex with the CI-MPR (space group P212121 - Form 1)monomer2347-2377
Assess
Crystal structure of the SNX5 PX domain in complex with the CI-MPR (space group P212121 - Form 1)monomer2347-2374
GOL;JEF;
Assess

10 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6z32.1.Amonomer0.82934-1646
99.86
Assess
6z32.2.Amonomer0.81933-1646
99.86
Assess
1q25.1.Amonomer0.7741-467
77.99
Assess
6um1.1.Amonomer0.7442-2282
NAG;NAG;NAG;81.18
Assess
6um2.1.Amonomer0.68472-2125
NAG;81.18
Assess
6z32.1.Amonomer0.60152-760
32.80
Assess
2v5o.1.Amonomer0.60627-1220
26.37
Assess
6z32.2.Amonomer0.5963-760
29.45
Assess
6um1.1.Amonomer0.5659-1990
29.55
Assess
6um2.1.Amonomer0.56171-1795
29.55
Assess